Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
Get Insiders for : 
Kalaris Therapeutics, Inc (KLRS)  
$2.67 0.05 (1.91%) as of 4:30 Mon 6/30


Download
   
Exchange: N/A
Security Type: Common
Shares Out: 61,660,000
Market Cap: 164.63(M)
Last Volume: 0 Avg Vol: 0
52 Week Range: $2.36 - $11
Level I Sector: N/A
Level II Sector: N/A
Level III Sector: N/A

Member Indexes:
   

Rankings:
     
Insider 3 Months    :   -
Insider 6 Months    :   -
Insider 3/6 Months :   -
Guru Rank Number :  -
Guru Rank Value     :  -
Guru Occurances    :  -

 

                 
 
Company Profile   AlloVir is a late clinical-stage cell therapy company developing allogeneic T-cell therapies to treat and prevent devastating viral diseases. Co.'s Pipeline includes: Posoloeucel, which is an allogeneic, off-the-shelf virus-specific T cell (VST) therapy candidate targeting adenovirus, BK virus, cytomegalovirus, Epstein-Barr virus, human herpesvirus 6 and JC virus that can lead to devastating viral disease in the allogeneic hematopoietic cell transplant population; and ALVR106, which is an allogeneic, off-the-shelf VST therapy candidate developed to target devastating diseases caused by human metapneumovirus, influenza, parainfluenza virus and respiratory syncytial virus.

 
 
Summary  (Direct Transactions Only) 3 Months 6 Months 12 Months 24 Months
Total Shares Bought 0 0 0 0
Total Buy Value $0 $0 $0 $0
Total People Bought 0 0 0 0
Total Buy Transactions 0 0 0 0
Total Shares Sold 0 3,349 105,868 371,645
Total Sell Value $0 $16,042 $92,804 $406,374
Total People Sold 0 3 4 4
Total Sell Transactions 0 10 49 111
End Date 2025-03-30 2024-12-27 2024-06-28 2023-06-29

   
Records found: 361
  Page 1 of 15  
Filer's Name Relation Title Off-Dir-10% Tran. Date Form Action Price Mkt Value D/I Shares Holdings
Rank

  
3m +/-  
Form
   Hagen Brett R Chief Accounting Officer   •       –      –    2025-03-26 4 S $8.97 $8,135 D/D (907) 1,925 72%     
   Samsara Biocapital, L.p. 10% Owner   –       –       •   2025-03-18 3 IO $0.00 $0 I/I 0 11,448,081     -
   Akkaraju Srinivas   –       •       •   2025-03-18 4 A $0.00 $0 I/I 11,444,503 11,444,503     -
   Patel Samir Chandrakant   –       •      –    2025-03-18 4 A $0.00 $0 I/I 100,800 100,800     -
   Patel Samir Chandrakant   –       •      –    2025-03-18 4 A $0.00 $0 D/D 252,000 252,000     -
   Ferrara Napoleone   –       •      –    2025-03-18 4 A $0.00 $0 D/D 504,000 504,000     -
   Feinsod Matthew Chief Medical Officer   •       –      –    2025-03-18 4 A $0.00 $0 D/D 4,030 4,030     -
   Hagen Brett R Chief Accounting Officer   •       –      –    2025-02-21 4 S $10.08 $967 D/D (96) 2,832     -
   Sinha Vikas See Remarks   •       •       •   2025-02-21 4 S $10.08 $3,053 D/D (303) 49,129     -
   Miller Edward General Counsel   •       –      –    2025-02-21 4 S $10.08 $1,068 D/D (106) 6,517     -
   Miller Edward General Counsel   •       –      –    2025-01-23 4 S $9.45 $494 D/D (52) 6,623     -
   Sinha Vikas See Remarks   •       •       •   2025-01-23 4 S $9.45 $1,226 D/D (129) 49,432     -
   Hagen Brett R Chief Accounting Officer   •       –      –    2025-01-23 4 S $9.45 $342 D/D (36) 2,928     -
   Sinha Vikas See Remarks   •       •       •   2025-01-10 4 S $0.44 $431 D/D (979) 1,139,915     -
   Hagen Brett R Chief Accounting Officer   •       –      –    2025-01-10 4 S $0.44 $146 D/D (332) 68,174     -
   Miller Edward General Counsel   •       –      –    2025-01-10 4 S $0.44 $180 D/D (409) 153,541     -
   Miller Edward General Counsel   •       –      –    2024-12-11 4 GA $0.00 $0 I/I 57,549 346,348     -
   Miller Edward General Counsel   •       –      –    2024-12-11 4 GD $0.00 $0 D/D 57,549 153,950     -
   Sinha Vikas See Remarks   •       •       •   2024-11-19 4 S $0.55 $1,748 D/D (3,186) 1,140,894     -
   Brainard Diana Chief Executive Officer   •       •      –    2024-11-19 4 S $0.55 $4,775 D/D (8,706) 723,363     -
   Miller Edward General Counsel   •       –      –    2024-11-19 4 S $0.55 $237 D/D (432) 211,499     -
   Hagen Brett R Chief Accounting Officer   •       –      –    2024-11-19 4 S $0.55 $304 D/D (554) 68,506     -
   Miller Edward General Counsel   •       –      –    2024-11-05 4 S $0.86 $1,965 D/D (2,272) 211,931     -
   Brainard Diana Chief Executive Officer   •       •      –    2024-11-05 4 S $0.86 $9,176 D/D (10,609) 732,069     -
   Sinha Vikas See Remarks   •       •       •   2024-11-05 4 S $0.86 $4,442 D/D (5,136) 1,144,080     -
  361 Records found
  1  2  3  4  5  6  7  8  9  Next   
  Page 1 of 15
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
  OE - Options Exercised A - Acquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2025 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us